Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 22, 2024, the ...

Nordson Test & Inspection today announced that it has earned the Prime Award, which is the top honor, at the Step-by-Step ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended ...

Acrivon Therapeutics, Inc. ("Acrivon” or "Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company ...

NEW YORK--(BUSINESS WIRE)--PartnerCentric, a leader in performance-driven affiliate marketing, launches two powerful ...

Cash position at September 30, 2024 was $1.3 million. The company announced on October 25, 2024, the exercise of outstanding warrants resulting in gross proceeds of $4.9 million. David Jenkins, CEO of ...